UPDATE
Obe-Cel Starts EMA Assessment in r/r B-ALL; April CHMP Agenda
On Monday, April 22, the CHMP Agenda for April was released. Of note, obe-cel (Autolus’s CD19 CAR-T) was included in the “Start of Procedure for New Application” section for the treatment of adult patients with r/r B-ALL.
We are sorry, but you do not have access to this information.
If you already have an account, please Login. If you have any questions or would like to subscribe to our services, please contact the Celltelligence team.
Contact Us